| Oct 13, 2025 |
Oct 15, 2025 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-1,076
|
-1.27%
|
✗
|
$71.7K |
| Mar 20, 2025 |
Mar 24, 2025 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-3,185
|
-3.75%
|
✗
|
$131.3K |
| Mar 10, 2025 |
Mar 12, 2025 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-3,966
|
-2.48%
|
✗
|
$169.2K |
| Feb 16, 2025 |
Feb 19, 2025 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
40.0
|
-11,542
|
-7.24%
|
✗
|
$619.5K |
| Oct 13, 2024 |
Oct 15, 2024 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-1,089
|
-1.71%
|
✗
|
$50.4K |
| Mar 10, 2024 |
Mar 12, 2024 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
40.0
|
-3,947
|
-3.15%
|
✗
|
$304.5K |
| Feb 18, 2024 |
Feb 21, 2024 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-1,913
|
-3.23%
|
✗
|
$152.4K |
| Mar 10, 2023 |
Mar 14, 2023 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-2,305
|
-2.08%
|
✗
|
$99.6K |
| Feb 18, 2023 |
Feb 22, 2023 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-1,950
|
-3.61%
|
✗
|
$94.1K |
| Dec 3, 2022 |
Dec 6, 2022 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-3,234
|
-6.05%
|
✗
|
$169K |
| Mar 10, 2022 |
Mar 14, 2022 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-2,360
|
-2.51%
|
✗
|
$146.1K |
| Dec 3, 2021 |
Dec 7, 2021 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
40.0
|
-6,303
|
-12.65%
|
✗
|
$436K |
| Sep 10, 2021 |
Sep 14, 2021 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
40.0
|
-4,741
|
-13.98%
|
✗
|
$558.8K |
| Mar 10, 2021 |
Mar 12, 2021 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
42.5
|
-1,353
|
-5.36%
|
✗
|
$168K |
| Jan 19, 2021 |
Jan 20, 2021 |
CRISPR Therapeutics AG
|
General Counsel and Secretary |
Sell |
3.8
|
-27,500
|
-55.08%
|
✓
|
$5.6M |